<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Palomero, Luis</style></author><author><style face="normal" font="default" size="100%">Galván-Femenía, Ivan</style></author><author><style face="normal" font="default" size="100%">de Cid, Rafael</style></author><author><style face="normal" font="default" size="100%">Espín, Roderic</style></author><author><style face="normal" font="default" size="100%">Barnes, Daniel R</style></author><author><style face="normal" font="default" size="100%">Blommaert, Eline</style></author><author><style face="normal" font="default" size="100%">Gil-Gil, Miguel</style></author><author><style face="normal" font="default" size="100%">Falo, Catalina</style></author><author><style face="normal" font="default" size="100%">Stradella, Agostina</style></author><author><style face="normal" font="default" size="100%">Ouchi, Dan</style></author><author><style face="normal" font="default" size="100%">Roso-Llorach, Albert</style></author><author><style face="normal" font="default" size="100%">Violan, Concepció</style></author><author><style face="normal" font="default" size="100%">Peña-Chilet, Maria</style></author><author><style face="normal" font="default" size="100%">Dopazo, Joaquin</style></author><author><style face="normal" font="default" size="100%">Extremera, Ana Isabel</style></author><author><style face="normal" font="default" size="100%">García-Valero, Mar</style></author><author><style face="normal" font="default" size="100%">Herranz, Carmen</style></author><author><style face="normal" font="default" size="100%">Mateo, Francesca</style></author><author><style face="normal" font="default" size="100%">Mereu, Elisabetta</style></author><author><style face="normal" font="default" size="100%">Beesley, Jonathan</style></author><author><style face="normal" font="default" size="100%">Chenevix-Trench, Georgia</style></author><author><style face="normal" font="default" size="100%">Roux, Cecilia</style></author><author><style face="normal" font="default" size="100%">Mak, Tak</style></author><author><style face="normal" font="default" size="100%">Brunet, Joan</style></author><author><style face="normal" font="default" size="100%">Hakem, Razq</style></author><author><style face="normal" font="default" size="100%">Gorrini, Chiara</style></author><author><style face="normal" font="default" size="100%">Antoniou, Antonis C</style></author><author><style face="normal" font="default" size="100%">Lázaro, Conxi</style></author><author><style face="normal" font="default" size="100%">Pujana, Miquel Angel</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Immune Cell Associations with Cancer Risk.</style></title><secondary-title><style face="normal" font="default" size="100%">iScience</style></secondary-title><alt-title><style face="normal" font="default" size="100%">iScience</style></alt-title></titles><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2020 Jul 24</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">23</style></volume><pages><style face="normal" font="default" size="100%">101296</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;Proper immune system function hinders cancer development, but little is known about whether genetic variants linked to cancer risk alter immune cells. Here, we report 57 cancer risk loci associated with differences in immune and/or stromal cell contents in the corresponding tissue. Predicted target genes show expression and regulatory associations with immune features. Polygenic risk scores also reveal associations with immune and/or stromal cell contents, and breast cancer scores show consistent results in normal and tumor tissue. SH2B3 links peripheral alterations of several immune cell types to the risk of this malignancy. Pleiotropic SH2B3 variants are associated with breast cancer risk in BRCA1/2 mutation carriers. A retrospective case-cohort study indicates a positive association between blood counts of basophils, leukocytes, and monocytes and age at breast cancer diagnosis. These findings broaden our knowledge of the role of the immune system in cancer and highlight promising prevention strategies for individuals at high risk.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">7</style></issue><custom1><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/32622267?dopt=Abstract</style></custom1></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Bonifaci, Núria</style></author><author><style face="normal" font="default" size="100%">Górski, Bohdan</style></author><author><style face="normal" font="default" size="100%">Masojć, Bartlomiej</style></author><author><style face="normal" font="default" size="100%">Wokołorczyk, Dominika</style></author><author><style face="normal" font="default" size="100%">Jakubowska, Anna</style></author><author><style face="normal" font="default" size="100%">Dębniak, Tadeusz</style></author><author><style face="normal" font="default" size="100%">Berenguer, Antoni</style></author><author><style face="normal" font="default" size="100%">Serra Musach, Jordi</style></author><author><style face="normal" font="default" size="100%">Brunet, Joan</style></author><author><style face="normal" font="default" size="100%">Dopazo, Joaquin</style></author><author><style face="normal" font="default" size="100%">Narod, Steven A</style></author><author><style face="normal" font="default" size="100%">Lubiński, Jan</style></author><author><style face="normal" font="default" size="100%">Lázaro, Conxi</style></author><author><style face="normal" font="default" size="100%">Cybulski, Cezary</style></author><author><style face="normal" font="default" size="100%">Pujana, Miguel Angel</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Exploring the link between germline and somatic genetic alterations in breast carcinogenesis.</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS One</style></secondary-title><alt-title><style face="normal" font="default" size="100%">PLoS One</style></alt-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Adult</style></keyword><keyword><style  face="normal" font="default" size="100%">Bone Morphogenetic Protein Receptors, Type I</style></keyword><keyword><style  face="normal" font="default" size="100%">Breast</style></keyword><keyword><style  face="normal" font="default" size="100%">Breast Neoplasms</style></keyword><keyword><style  face="normal" font="default" size="100%">Calcium-Calmodulin-Dependent Protein Kinases</style></keyword><keyword><style  face="normal" font="default" size="100%">Case-Control Studies</style></keyword><keyword><style  face="normal" font="default" size="100%">Cyclin-Dependent Kinases</style></keyword><keyword><style  face="normal" font="default" size="100%">Disease Progression</style></keyword><keyword><style  face="normal" font="default" size="100%">Estrogen Receptor alpha</style></keyword><keyword><style  face="normal" font="default" size="100%">Female</style></keyword><keyword><style  face="normal" font="default" size="100%">Gene Frequency</style></keyword><keyword><style  face="normal" font="default" size="100%">Genetic Predisposition to Disease</style></keyword><keyword><style  face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style  face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style  face="normal" font="default" size="100%">Germ-Line Mutation</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style  face="normal" font="default" size="100%">Poland</style></keyword><keyword><style  face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style  face="normal" font="default" size="100%">Protein Serine-Threonine Kinases</style></keyword><keyword><style  face="normal" font="default" size="100%">Protein-Tyrosine Kinases</style></keyword><keyword><style  face="normal" font="default" size="100%">Receptor Protein-Tyrosine Kinases</style></keyword><keyword><style  face="normal" font="default" size="100%">Receptor, EphA3</style></keyword><keyword><style  face="normal" font="default" size="100%">Receptor, EphA7</style></keyword><keyword><style  face="normal" font="default" size="100%">Receptor, EphB1</style></keyword><keyword><style  face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2010</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2010 Nov 22</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">5</style></volume><pages><style face="normal" font="default" size="100%">e14078</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;Recent genome-wide association studies (GWASs) have identified candidate genes contributing to cancer risk through low-penetrance mutations. Many of these genes were unexpected and, intriguingly, included well-known players in carcinogenesis at the somatic level. To assess the hypothesis of a germline-somatic link in carcinogenesis, we evaluated the distribution of somatic gene labels within the ordered results of a breast cancer risk GWAS. This analysis suggested frequent influence on risk of genetic variation in loci encoding for &quot;driver kinases&quot; (i.e., kinases encoded by genes that showed higher somatic mutation rates than expected by chance and, therefore, whose deregulation may contribute to cancer development and/or progression). Assessment of these predictions using a population-based case-control study in Poland replicated the association for rs3732568 in EPHB1 (odds ratio (OR) = 0.79; 95% confidence interval (CI): 0.63-0.98; P(trend) = 0.031). Analyses by early age at diagnosis and by estrogen receptor α (ERα) tumor status indicated potential associations for rs6852678 in CDKL2 (OR = 0.32, 95% CI: 0.10-1.00; P(recessive) = 0.044) and rs10878640 in DYRK2 (OR = 2.39, 95% CI: 1.32-4.30; P(dominant) = 0.003), and for rs12765929, rs9836340, rs4707795 in BMPR1A, EPHA3 and EPHA7, respectively (ERα tumor status P(interaction)&lt;0.05). The identification of three novel candidates as EPH receptor genes might indicate a link between perturbed compartmentalization of early neoplastic lesions and breast cancer risk and progression. Together, these data may lay the foundations for replication in additional populations and could potentially increase our knowledge of the underlying molecular mechanisms of breast carcinogenesis.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">11</style></issue><custom1><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/21124932?dopt=Abstract</style></custom1></record></records></xml>